QDEL
Q3 2026 EPS Estimate
$-0.04
Aug 6, 2026 · Reports after close
Revenue Estimate
$620M
FY2026E EPS$1.85
FY2027E EPS$2.46

Analyst Sentiment

Wall St. Consensus
Hold
15 analysts·Moderate coverage
57
Score
6 Buy (40%)7 Hold (47%)2 Sell (13%)
Rating Breakdown
Strong Buy
00%
Buy
640%
Hold
747%
Sell
213%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$12.00
-27.3%
Consensus
$12.25
-25.8%
Bull
$12.50
-24.2%
12-Month Target Range15 analysts
$12.00$12.25$12.50
Current $16.50Consensus
Current Price
$16.50
Above Consensus
$4.25

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+3.28%
EPS+32.54%
FY2028
Rev+4.08%
EPS+19.81%
FY2029
Rev+3.77%
EPS+7.30%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027EFY2028EFY2029EFY2030E
Revenue Avg$2.71B$2.80B$2.91B$3.02B$2.83B
Low$2.68B$2.77B$2.86B$2.99B$2.80B
High$2.74B$2.83B$2.97B$3.06B$2.86B
EBITDA Avg$208M$215M$224M$233M$217M
Low$206M$213M$220M$230M$215M
High$211M$218M$228M$235M$220M
EBIT Avg$-114M$-118M$-123M$-127M$-119M
Low$-115M$-119M$-125M$-129M$-120M
High$-113M$-117M$-120M$-126M$-118M
Net Income Avg$127M$167M$200M$214M$61M
Low$124M$164M$197M$211M$60M
High$127M$169M$202M$217M$62M
EPS Avg$1.85$2.46$2.94$3.16$0.90
Low$1.83$2.43$2.91$3.12$0.89
High$1.88$2.49$2.99$3.20$0.91
Analysts (Rev / EPS)3 / 13 / 12 / 11 / 11 / 1
Quarterly
MetricQ3 2026Q4 2026Q1 2027Q2 2027Q3 2027Q4 2027Q1 2028Q2 2028
Revenue Avg$716M$754M$642M$626M$731M$771M$661M$665M
Low$713M$751M$638M$623M$727M$767M$657M$662M
High$718M$756M$643M$627M$732M$773M$662M$667M
EBITDA Avg$55M$58M$49M$48M$56M$59M$51M$51M
Low$55M$58M$49M$48M$56M$59M$51M$51M
High$55M$58M$49M$48M$56M$59M$51M$51M
EBIT Avg$-30M$-32M$-27M$-26M$-31M$-32M$-28M$-28M
Low$-30M$-32M$-27M$-26M$-31M$-33M$-28M$-28M
High$-30M$-32M$-27M$-26M$-31M$-32M$-28M$-28M
Net Income Avg$61M$70M$751,632$9M$69M$85M$43M$42M
Low$61M$70M$746,556$9M$69M$85M$42M$42M
High$61M$70M$753,685$9M$69M$85M$43M$42M
EPS Avg$0.90$1.03$0.01$0.13$1.01$1.25$0.63$0.62
Low$0.89$1.02$0.01$0.13$1.01$1.24$0.62$0.61
High$0.90$1.03$0.01$0.13$1.02$1.25$0.63$0.62
Analysts (Rev / EPS)2 / 21 / 11 / 11 / 11 / 11 / 11 / 11 / 1

Earnings Surprises

Recent Analyst Actions

May 7, 2026UBS
QuidelOrtho price target lowered to $12 from $17 at UBS
Target:$12.00
+11.7%from $10.74
May 7, 2026Jefferies
QuidelOrtho downgraded to Hold from Buy at Jefferies
Target:$12.50
+14.1%from $10.96
Apr 10, 2026UBS
QuidelOrtho price target lowered to $17 from $30 at UBS
Target:$17.00
+22.0%from $13.94
Feb 12, 2026UBS
QuidelOrtho price target lowered to $30 from $35 at UBS
Target:$30.00
+29.4%from $23.19
Jan 21, 2026UBS
QuidelOrtho price target raised to $35 from $31 at UBS
Target:$35.00
+6.9%from $32.73
Sep 19, 2024UBS
QuidelOrtho assumed with Neutral from Sell at UBS
Target:$50.00
+8.2%from $46.23
Sep 5, 2024Craig-Hallum
Craig-Hallum Upgrades Quidel Corp. (QDEL) to Buy
Target:$57.00
+32.8%from $42.93
Aug 15, 2023Raymond James
Analyst Is Frustrated By QuidelOrtho's Reduction In Guidance - Here's Why
Target:$110.00
+47.7%from $74.47
Dec 12, 2022Citigroup
Citigroup Upgrades QuidelOrtho to Buy, Raises Price Target to $125
Target:$125.00
+35.4%from $92.30
Dec 7, 2022RBC Capital
RBC Capital Initiates Coverage On QuidelOrtho with Outperform Rating, Announces Price Target of $125
Target:$125.00
+35.6%from $92.19
Oct 14, 2022UBS
UBS Upgrades Quidel Corp. (QDEL) to Neutral
Target:$86.00
+12.6%from $76.38
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.